关注
Siqi Chen
Siqi Chen
在 coh.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
N (6)‐methyladenosine‐binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay
TL Xia, X Li, X Wang, YJ Zhu, H Zhang, W Cheng, ML Chen, Y Ye, Y Li, ...
EMBO reports 22 (4), e50128, 2021
712021
Harnessing and enhancing macrophage phagocytosis for cancer therapy
S Chen, SWT Lai, CE Brown, M Feng
Frontiers in Immunology 12, 635173, 2021
672021
Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription
S Chen, L Su, J Qiu, N Xiao, J Lin, J Tan, T Ou, L Gu, Z Huang, D Li
Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (10), 4769-4777, 2013
602013
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer
X Cao, B Li, J Chen, J Dang, S Chen, EG Gunes, B Xu, L Tian, S Muend, ...
Journal for ImmunoTherapy of Cancer 9 (3), 2021
582021
Bispecific antibodies in cancer immunotherapy
S Chen, J Li, Q Li, Z Wang
Human vaccines & immunotherapeutics 12 (10), 2491-2500, 2016
582016
Tumor cell-secreted ISG15 promotes tumor cell migration and immune suppression by inducing the macrophage M2-like phenotype
RH Chen, ZW Xiao, XQ Yan, P Han, FY Liang, JY Wang, ST Yu, TZ Zhang, ...
Frontiers in Immunology 11, 594775, 2020
562020
A novel bispecific antibody, BiSS, with potent anti-cancer activities
B Dong, C Zhou, P He, J Li, S Chen, J Miao, Q Li, Z Wang
Cancer biology & therapy 17 (4), 364-370, 2016
332016
Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity
J Li, C Zhou, B Dong, H Zhong, S Chen, Q Li, Z Wang
Cancer Biology & Therapy 17 (12), 1231-1239, 2016
312016
Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells
N Xiao, S Chen, Y Ma, J Qiu, JH Tan, TM Ou, LQ Gu, ZS Huang, D Li
Biochemical and Biophysical Research Communications 419 (3), 567-572, 2012
312012
A novel bispecific antibody, S-Fab, induces potent cancer cell killing
L Li, P He, C Zhou, L Jing, B Dong, S Chen, N Zhang, Y Liu, J Miao, ...
Journal of Immunotherapy 38 (9), 350-356, 2015
302015
Warburg effect is a cancer immune evasion mechanism against macrophage immunosurveillance
J Chen, X Cao, B Li, Z Zhao, S Chen, SWT Lai, SA Muend, GK Nossa, ...
Frontiers in immunology 11, 621757, 2021
292021
Cellular nucleic acid binding protein suppresses tumor cell metastasis and induces tumor cell death by downregulating heterogeneous ribonucleoprotein K in fibrosarcoma cells
J Qiu, S Chen, L Su, J Liu, N Xiao, TM Ou, JH Tan, LQ Gu, ZS Huang, D Li
Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (7), 2244-2252, 2014
242014
A targeted IL-15 fusion protein with potent anti-tumor activity
S Chen, Q Huang, J Liu, J Xing, N Zhang, Y Liu, Z Wang, Q Li
Cancer biology & therapy 16 (9), 1415-1421, 2015
232015
Cobalt chloride-induced hypoxia induces epithelial-mesenchymal transition in renal carcinoma cell lines
N Zhang, B Hong, C Zhou, X Du, S Chen, X Deng, S Duoerkun, Q Li, ...
Annals of Clinical & Laboratory Science 47 (1), 40-46, 2017
212017
A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities
X Wu, S Chen, L Lin, J Liu, Y Wang, Y Li, Q Li, Z Wang
Translational oncology 11 (2), 366-373, 2018
162018
Targeting tumor-associated macrophages for cancer immunotherapy
X Cao, SWT Lai, S Chen, S Wang, M Feng
International Review of Cell and Molecular Biology 368, 61-108, 2022
142022
UHRF1 controls thymocyte fate decisions through the epigenetic regulation of EGR1 expression
Y Zhang, Y Chen, R Ma, Y Jiang, J Liu, Y Lin, S Chen, M Xia, F Zou, ...
The Journal of Immunology 204 (12), 3248-3261, 2020
112020
Prodrug AST-003 improves the therapeutic index of the multi-targeted tyrosine kinase inhibitor sunitinib
Q Huang, C Zhou, X Chen, B Dong, S Chen, N Zhang, Y Liu, A Li, M Yao, ...
PloS one 10 (10), e0141395, 2015
102015
Pro-phagocytic function and structural basis of GPR84 signaling
X Zhang, Y Wang, S Supekar, X Cao, J Zhou, J Dang, S Chen, L Jenkins, ...
Nature Communications 14 (1), 5706, 2023
92023
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL
Y Chen, Y Zhang, S Chen, W Liu, Y Lin, H Zhang, F Yu
Pigment Cell & Melanoma Research 35 (2), 238-251, 2022
72022
系统目前无法执行此操作,请稍后再试。
文章 1–20